(2026). GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer. EJNMMI Research.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"GWAS from a Multicenter Prospective Study of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer."
EJNMMI Research 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"GWAS from a Multicenter Prospective Study of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer."
EJNMMI Research, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.